IDO1 and neoplasm: Targeting IDO1 in combination with metabolic inhibitors offers a promising therapeutic avenue, as IDO1 blockade (using Epacadostat, Navoximod, Indoximod, etc.)may restore anti-tumor immunity while disrupting metabolic adaptation.